Veterans Aging Cohort Study Site Evaluations

Slides:



Advertisements
Similar presentations
Tips to a Successful Monitoring Visit
Advertisements

Common Errors to avoid in IRB- 03 (VA) Applications.
DHMH Institutional Review Board Research, Respect and Responsibility.
Highlights of MACS and WIHS Protocol and Cohorts Lisa Jacobson Stephen Gange May 25, 2005 Not for distribution or publication outside the Multicenter AIDS.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Capture of acute myocardial infarctions occurring at non-VA hospitals by outpatient, VA Healthcare System ICD-9 codes CONCLUSIONS 1.NVH records can be.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Generously supported by the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Veteran Affairs, and National Institutes of Health,
OVERVIEW OF PROJECT INSPIRE NYC Marie Bresnahan, MPH Project Director May 20,
Veterans Aging Cohort Study (VACS)
How to Start An Industry Sponsored Clinical Trial
Effects of Alcohol and Crack Cocaine Use on Virological and Immunological Disease Progression in a Cohort of U.S. Women with HIV/AIDS Judith A. Cook, Ph.D.
Juvenile Legislative Update 2013 Confidential Records and Protected Disclosures.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Good Clinical Practice (GCP) and Monitoring Practices
HIV infection and the risk of peripheral artery disease
Medical Assistance for Women with Breast or Cervical Cancer
CDC’s 6|18 Initiative: Accelerating Evidence into Action American College of Preventive Medicine Utilizing the 6|18 Initiative to Address High Blood.
Veterans Aging Cohort Study (VACS)
UMRG 3rd Learning Session: July 19th, 2012
VACS Cancer Core Robert Dubrow, PhD, MD Founding Director
Systems Expansion in Global Surgery: Needs Assessment and Feasibility of Prospective Data Registry Development for Prehospital Care in Cali, Colombia Zina.
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
VACS Alcohol and Behavior Change Core
Art.
HSR Core Co-Chairs: Emily Wang, MD Kathleen McGinnis, DrPH
Janet P. Tate, MPH, ScD Co-Director
Confidential Records and Protected Disclosures
Maria Rodriguez-Barradas
VACS Cardiovascular Disease Core
VA Update Northwest Portland Area Indian Health Board Quarterly Meeting Portland, OR January 16, 2018 Introduction.
VACS Cardiovascular Disease Core
Surveillance Databases: Clinical Case Registry (CCR), NSQUIP, and VACS
VACS Scientific Meeting 2010
RL Cook, KA McGinnis, DA Fiellin, JH Samet, JL Goulet, S Crystal
Quality of HIV Care and Mortality in HIV-Infected Patients Who Use Drugs and Alcohol PT Korthuis, KL Kraemer, KA McGinnis, M Skanderson, AJ Gordon, AC.
Assembling a Fuller Picture of Ryan White Part A Clients Using Data from Program Reporting, Surveillance, Claims, and Surveys Jacinthe Thomas, MPH Manager.
Variation in Veterans’ Access to Internet and Potential Impact on VHA Electronic Health Communication Thank you Joanne. Hello and welcome everyone,
A Multimodal Intervention for Veterans with HIV Infection
Kendall Bryant, PhD for the VACS Project Team RSA: July 8th, 2007
Clinical Effectiveness, Surrogate Outcomes, and Multimorbidity
Amy C. Justice, MD, PhD For the VACS Project Team
VACS Scientific Meeting October 15, 2008 Joseph K. Lim, M.D.
Relevance and risks of cigarette smoking for HIV-infected patients
Phenotyping Using Longitudinal VA Electronic Health Data
Update on the VACS New ART Initiator Protocol and Substudy
Integrating and Prioritizing HIV and “non HIV” Care in the cART Era
Depression Treatment in HIV-infected and Uninfected Veterans: Do Rates Vary by HIV Status? Kristen Sueoka YSM IV.
Quality of HIV Care for Veterans with Unhealthy Alcohol Use
Targeting Clinical Intervention Among Veterans with HIV Infection: Adherence, Alcohol, and Non-ARV Treatment Toxicity University of Pennsylvania Center.
Farah Kidwai-Khan, Janet Tate, Cynthia Brandt, Amy Justice
Veterans Aging Cohort Studies (VACS) Update 2008
HIV and Aging: The Importance of a Nuanced Approach
for the Veterans Aging Cohort Study
Comparative Effectiveness of Alcohol and Drug Treatment in HIV Infected Veterans Kevin L. Kraemer, MD, MSc Professor of Medicine and Clinical & Translational.
The Power of Propensity Score Matching to Remove Confounding by Indication:  Statins and Acute Myocardial Infarction among HIV Infected and Uninfected.
HSR Core Co-Chairs: Emily Wang, MD Kathleen McGinnis, DrPH
Patterns, predictors, and consequences of non-medical use prescription opioids in the Veterans Aging Cohort Study Brandon DL Marshall, PhD Manning Assistant.
The Veterans Aging Cohort Study: Understanding and Improving Outcomes in HIV Infection David Fiellin, MD, Cynthia Brandt, MD and Amy Justice, MD, PhD.
VACS Antiviral Workgroup
VACS Scientific Meeting 2008
Cross CHAART Working Groups
VACS Mental Health WG Joseph L. Goulet, PhD, MS Director
VACS Scientific Meeting Houston, TX February 2004
for the VACS Project Team
Update on the VACS HIV CVD Substudy and Preliminary Analyses
Lung Diseases in HIV-infected Veterans
VACS Scientific Meeting 2016
HIV and Aging: The Spectrum of Disease Changes
Medical Assistance for Women with Breast or Cervical Cancer
Presentation transcript:

Veterans Aging Cohort Study Site Evaluations Overview of 2005-2006 Site Visits & Future Evaluation Criteria Deborah. V. Gibson, MA Kristin Mattocks, PhD, MPH

General Overview of Site Visit The intent was to: Evaluate progress made to date Highlight areas that are working well Identify areas that could be improved and add to the continued success of the site.

General Overview of Site Visit Areas of evaluation: Proper storage of patient data (to ensure confidentiality): Assessment of management, documentation, and storage of consents, surveys, and payment receipts Interaction with the site over the past year, including: Participation in conference calls Timeliness of information submitted to the CC Site performance in FU Surveys, DNA/Blood Study, regulatory matters (IRB) & other substantive areas

Confidentiality of Patient Data

Analysis of 10 Randomly Selected Files

Site Participation & Communication (ID & GM included separately where needed)

Follow Up #3 Survey Performance

DNA / Blood Study Performance

Regulatory Performance

Summary of Findings Most sites performing very well with regard to enrollment, retention, shipment of paperwork to CC & Palo Alto, and regulatory (IRB) matters. Improvement in attention to details on Follow Up & DNA/Blood study paperwork would help reduce Coordinator & CC workload.

Future Evaluation Criteria Some evaluation metrics will remain the same, others will evolve as study evolves: Proper storage of patient documents Adherence to blood/DNA study protocols (including enrollment and documentation regarding refusal to participate in blood/DNA substudy) Enrollment protocols/standards (Fall 2007) Proper use of Cause of Death and HAART Naïve documentation Adherence to VA electronic security standards

Acknowledgements PI and Co-PI: AC Justice, DA Fiellin Participating VA Medical Centers: Atlanta (D. Rimland, C Jones-Taylor), Baltimore (KA Oursler, R Titanji), Bronx (S Brown, S Garrison), Houston (M Rodriguez-Barradas, N Masozera), Los Angeles (M Goetz, D Leaf), Manhattan-Brooklyn (M Simberkoff, D Blumenthal, J Leung), Pittsburgh (A Butt, E Hoffman), and Washington DC (C Gibert, R Peck) Core Faculty: S Braithwaite, C Brandt, K Bryant, R Cook, J Conigliaro, K Crothers, J Chang, S Crystal, N Day, J Erdos, M Freiberg, M Kozal, M Gaziano, M Gerschenson, B Good, A Gordon, J Goulet, M Hernan, K Kraemer, J Lim, S Maisto, K Mattocks, P Miller, L Mole, P O’Connor, R Papas, H Paek, J Robins, C Rinaldo, M Roberts, J Samet, B Tierney, J Whittle Staff: D Cohen, A Consorte, D Gibson, K Gordon, F Kidwai, F Levin, K McGinnis, M Rambo, J Rogers, M Skanderson, F Whitsett Major Collaborators: Immunology Case Registry, Pharmacy Benefits Management, Framingham Heart Study, Women’s Interagency HIV Study, Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Health Economics Research Center (HERC), Center for Health Equity Research and Promotion (CHERP) Funded by: National Institute on Alcohol Abuse and Alcoholism (2U10 AA 13566); National Institute on Aging (K23 G00826); Robert Wood Johnson Generalist Faculty Scholar Award; an Inter-Agency Agreement between National Institute on Aging, National Institute of Mental Health, and the Veterans Health Administration; the VHA Office of Research and Development; and, VHA Public Health Strategic Health Care Group.